MENU
+Compare
STIM
Stock ticker: NASDAQ
AS OF
Dec 24 closing price
Price
$1.42
Change
-$0.01 (-0.70%)
Capitalization
97.25M

STIM Neuronetics Forecast, Technical & Fundamental Analysis

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders... Show more

STIM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for STIM with price predictions
Dec 24, 2025

STIM in -7.79% downward trend, falling for three consecutive days on December 24, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where STIM declined for three days, in of 318 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 50 cases where STIM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

STIM broke above its upper Bollinger Band on December 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for STIM entered a downward trend on December 04, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where STIM's RSI Indicator exited the oversold zone, of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 19, 2025. You may want to consider a long position or call options on STIM as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for STIM just turned positive on December 03, 2025. Looking at past instances where STIM's MACD turned positive, the stock continued to rise in of 35 cases over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where STIM advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.555) is normal, around the industry mean (63.841). P/E Ratio (0.000) is within average values for comparable stocks, (37.253). STIM's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.634). STIM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (0.635) is also within normal values, averaging (36.935).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. STIM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STIM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
STIM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

STIM is expected to report earnings to fall 29.08% to -9 cents per share on March 10

Neuronetics STIM Stock Earnings Reports
Q4'25
Est.
$-0.09
Q3'25
Est.
$-0.13
Q2'25
Missed
by $0.07
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.09
The last earnings report on November 04 showed earnings per share of -12 cents, meeting the estimate of -12 cents. With 1.21M shares outstanding, the current market capitalization sits at 97.25M.
A.I. Advisor
published General Information

General Information

a developer of non-invasive therapies for psychiatric and neurological disorders

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3222 Phoenixville Pike
Phone
+1 610 640-4202
Employees
203
Web
https://www.neurostar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HCHDF6.860.18
+2.66%
Hochschild Mining PLC
AGTX0.04N/A
N/A
Agentix Corp.
AHCHF2.80N/A
N/A
Anhui Conch Cement Co., Ltd.
LTRBF0.01N/A
N/A
LATROBE MAGNESIUM LTD.
SFSVF76.62N/A
N/A
Software Service, Inc.

STIM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, STIM has been loosely correlated with TMCI. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if STIM jumps, then TMCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STIM
1D Price
Change %
STIM100%
-0.70%
TMCI - STIM
35%
Loosely correlated
+2.52%
MASI - STIM
33%
Loosely correlated
-0.44%
ARAY - STIM
33%
Loosely correlated
+0.43%
DCTH - STIM
31%
Poorly correlated
+1.98%
MXCT - STIM
31%
Poorly correlated
+3.23%
More

Groups containing STIM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STIM
1D Price
Change %
STIM100%
-0.70%
Medical/Nursing Services
industry (213 stocks)
31%
Poorly correlated
+0.01%
Health Services
industry (404 stocks)
1%
Poorly correlated
-0.05%